← Back to Search

Procedure

Coblation for Obstructive Sleep Apnea

N/A
Waitlist Available
Led By Derek S Drummond, MD, MPH
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months and 2 years post-op
Awards & highlights

Study Summary

Removal of the adenoid and tonsils, known as an adenotonsillectomy (AT) is one of the most frequently performed surgical procedures in North America. The two most prevalent indications for this procedure in children are recurrent bacterial tonsillitis and obstructive sleep apnea (OSA). OSA is a common childhood condition that is characterized by upper airway obstruction, disturbed sleep and disrupted normal respiratory gas exchange. In the majority of children with OSA, overgrowth of the adenoid and tonsils is the primary underlying aetiology, making tissue removal via AT the standard of care. The purpose of this study is to evaluate the effectiveness of two different surgical techniques, electrocautery-tonsillectomy and coblation-tonsillotomy, in the treatment of obstructive sleep apnea (OSA) in children.

Eligible Conditions
  • Obstructive Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months and 2 years post-op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months and 2 years post-op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Compare coblation-tonsillotomy to electrocautery-tonsillectomy as a treatment of obstructive sleep apnea (OSA), as assessed by apnea-hypopnea index (AHI) measured on polysomnography (PSG)
Secondary outcome measures
Evaluate post-operative pain and analgesic use associated with electrocautery-tonsillectomy and coblation-tonsillotomy
Evaluate quality of life following coblation-tonsillotomy and electrocautery-tonsillectomy for the treatment of OSA

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CoblationExperimental Treatment1 Intervention
Group II: ElectrocauteryActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of CalgaryLead Sponsor
789 Previous Clinical Trials
868,208 Total Patients Enrolled
ArthroCare CorporationOTHER
11 Previous Clinical Trials
436 Total Patients Enrolled
Calgary Health RegionOTHER
12 Previous Clinical Trials
5,571 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025